Current Report Filing (8-k)
September 02 2022 - 04:31PM
Edgar (US Regulatory)
0001326706 false 0001326706 2022-09-02
2022-09-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
September 2, 2022
NanoVibronix, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
|
001-36445 |
|
01-0801232 |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
525 Executive Blvd.,
Elmsford,
NY
10523
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
(914)
233-3004
Not Applicable
(Former
name or former address, if changed since last
report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| |
|
|
☒ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
|
|
☐ |
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
|
|
☐ |
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17
CFR §240.12b-2).
Emerging
growth company
☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
|
Common Stock, par value $0.001 per share |
|
NAOV |
|
Nasdaq Capital Market |
Item
8.01. Other Events.
The Company previously disclosed that it intended to hold its
Annual Meeting of Shareholders (the “Annual Meeting”) on September
14, 2022. The Company has determined to postpone the Annual Meeting
until later this year.
The
date of the rescheduled annual meeting, and the new record date for
determining the NanoVibronix stockholders entitled to vote thereat,
will be determined in the near future, and will be included in
proxy materials to be filed with the SEC and distributed to
stockholders promptly after the new record date.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
| |
NANOVIBRONIX,
INC. |
| |
|
|
Date:
September 2, 2022 |
By: |
/s/
Stephen Brown |
| |
Name: |
Stephen
Brown |
| |
Title: |
Chief
Financial Officer |
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Dec 2022 to Jan 2023
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jan 2022 to Jan 2023
